Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
1996

Matrix Metalloproteinases and Gastric Cancer Survival

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): CFM Sierl, FJGM Kubben, S Ganeshl, MM Heerding, G Griffioen, R Hanemaaijer, JHJM van Krieken, CBHW Lamers, HW Verspaget

Primary Institution: University Hospital, Leiden

Hypothesis

High levels of matrix metalloproteinases MMP-2 and MMP-9 are associated with poor overall survival in gastric carcinoma patients.

Conclusion

The study found that elevated levels of MMP-2 and MMP-9 in gastric carcinomas are linked to a worse survival outcome for patients.

Supporting Evidence

  • 82% of gastric carcinomas contained more total MMP-2 than adjacent mucosa.
  • 80% of gastric carcinomas contained more total MMP-9 than adjacent mucosa.
  • High levels of MMP-2 and MMP-9 were associated with poor overall survival.
  • Survival decreased with increasing TNM stage.

Takeaway

This study shows that higher amounts of certain proteins in stomach cancer can mean patients might not live as long.

Methodology

The study used quantitative gelatin zymography to measure MMP levels in tissue samples from gastric cancer patients.

Limitations

The number of patients in the study is relatively low.

Participant Demographics

76% of the patients were male, with a mean age of approximately 67 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication